Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
394371000036118 | Tisseel VH S/D (aprotinin 2250 KI units / 1 mL + calcium chloride dihydrate 3.96 mg / 1 mL + factor XIII 1.2 international units / 1 mL + fibrinogen 72 mg / 1 mL + human thrombin 400 international units / 1 mL) solution, 4 mL, dual chamber syringe (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
394381000036116 | Tisseel VH S/D solution, 4 mL, dual chamber syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Tisseel VH S/D solution, 4 mL, dual chamber syringe | Is a | containered trade product pack | false | Inferred relationship | Some | ||
Tisseel VH S/D solution, 4 mL, dual chamber syringe | Is a | Tisseel VH S/D solution, 4 mL | false | Inferred relationship | Some | ||
Tisseel VH S/D solution, 4 mL, dual chamber syringe | has container type | dual chamber syringe | false | Inferred relationship | Some | ||
Tisseel VH S/D solution, 4 mL, dual chamber syringe | has TPUU | Tisseel VH S/D solution | false | Inferred relationship | Some | ||
Tisseel VH S/D solution, 4 mL, dual chamber syringe | has TP | Tisseel VH S/D | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set